27 Mar 2019
Surveillance for Antimicrobial Resistance in South Africa-Report Following a global initiative of combating antimicrobial resistance, South Africa developed the Antimicrobial Resistance National Strategic Framework, 2014-2024. The AMR Strategy Framework consists of five objectives: 1. Diagnostic stewardship 2. Enhanced surveillance for AMR 3. Antimicrobial stewardship 4. Prevention including IPCs 5. Vaccination.
The enhanced surveillance report aimed to generate a consolidated observation of susceptibility pattern to antimicrobials in humans and animals. In addition, this report presents antimicrobial use in humans and animals. Unfortunately, no data on AMR surveillance in animals have been available and an initiative to integrate these two sectors is under review. Antimicrobial resistance in humans This report facilitated by the South African Society for Clinical Microbiology (SASCM), presented data from blood culture specimens for all public and the majority of private healthcare facilities that are served by four private laboratory groups (Lancet, Ampath, Vermaak and Partners and PathCare). The custodian of this data is the National Institute for Communicable Disease (NICD) and this dynamic interactive search on drug/bug combination can be obtained at the website: http://www.nicd.ac.za. We report on ESKAPE organisms: Enterococcus faecalis and Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli.
We report susceptibility trends over a six-year period.
Key findings include:
There are a number of limitations that need to be acknowledged: